Bipartisan Treat and Reduce Obesity Act would authorize Medicare Part D GLP-1 weight loss coverage

Filed 15 October 2026, the bill would expand prescription drug coverage for weight management medications.

Stands on 4 placed sources from 3 publishers.

Bipartisan federal legislation titled the Treat and Reduce Obesity Act would authorize Medicare Part D coverage of GLP-1 medications for weight loss. ^[1] The bill was filed 15 October 2026. Finance and insurance professional Bobby Garon stated that rising Medicare Part B premiums will reduce the net benefit most retirees receive from the 2027 cost of living adjustment. ^[2] Medicare Advantage plans are offered by private insurance companies approved by the Centers for Medicare & Medicaid Services. ^[3] All such plans are required to cover every service included in traditional Medicare Part A hospital insurance and Part B medical insurance. ^[4]

Proof4 sources · 3 publishers · signed

What this stands on

Bipartisan legislation known as the Treat and Reduce Obesity Act would authorize Medicare Part D to cover GLP-1 medications for weight loss. · Cato Institute
Finance and insurance professional Bobby Garon stated that rising Medicare Part B premiums will reduce the net benefit most retirees receive from the 2027 COLA. · Cision PR Newswire
Medicare Advantage plans are offered by private insurance companies that are approved by the Centers for Medicare & Medicaid Services (CMS) to provide Medicare benefits. · Tampa Bay Times
Medicare Advantage plans must cover all services included in traditional Medicare Part A (hospital insurance) and Part B (medical insurance). · Tampa Bay Times

We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.